Sotera Health (NASDAQ:SHC - Get Free Report) issued its earnings results on Thursday, May 1st. The company reported $0.14 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.12 by $0.02, Briefing.com reports. The company had revenue of $254.52 million during the quarter, compared to analysts' expectations of $245.56 million. Sotera Health had a return on equity of 42.27% and a net margin of 6.31%. The firm's quarterly revenue was up 2.6% on a year-over-year basis. During the same period in the prior year, the business earned $0.13 EPS. Sotera Health updated its FY 2025 guidance to 0.700-0.760 EPS.
Sotera Health Trading Up 0.6 %
Shares of SHC stock traded up $0.08 during mid-day trading on Thursday, reaching $13.23. The company's stock had a trading volume of 1,011,205 shares, compared to its average volume of 1,209,826. The firm has a market capitalization of $3.76 billion, a PE ratio of 52.92 and a beta of 1.88. The company has a quick ratio of 2.61, a current ratio of 2.88 and a debt-to-equity ratio of 4.91. Sotera Health has a 12-month low of $9.53 and a 12-month high of $17.08. The company's 50 day simple moving average is $11.39 and its 200-day simple moving average is $12.98.
Wall Street Analysts Forecast Growth
A number of research analysts recently weighed in on SHC shares. Barclays dropped their price objective on shares of Sotera Health from $16.00 to $12.00 and set an "overweight" rating for the company in a report on Thursday, April 10th. The Goldman Sachs Group raised shares of Sotera Health from a "neutral" rating to a "buy" rating and boosted their price target for the company from $14.00 to $17.00 in a research report on Monday. Finally, Piper Sandler cut their target price on shares of Sotera Health from $15.00 to $13.00 and set a "neutral" rating on the stock in a report on Wednesday, April 23rd. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $15.80.
Read Our Latest Stock Report on SHC
Sotera Health Company Profile
(
Get Free Report)
Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.
Further Reading
Before you consider Sotera Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sotera Health wasn't on the list.
While Sotera Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
